# PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis

> **NCT02874066** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 46 (actual)

## Conditions studied

- Hepatitis Viruses

## Interventions

- **DRUG:** PTV/r/OBV/DSV

## Key facts

- **NCT ID:** NCT02874066
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-13
- **Primary completion:** 2018-10-30
- **Final completion:** 2018-12-25
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02874066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02874066, "PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02874066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*